
ObGyn Week in Review - July 27, 2012/
Cancer passed in utero, trading art for health care, urinary incontinence in young women and more in the ob/gyn week in review.
Mother Passed Cancer to her Fetus
A
Trading Art for Healthcare
A
Verdict in Vaginal Mesh Suit Holds Both Manufacturer and Physician Responsible
The first lawsuit to go to trial against C.R. Bard Inc., over injury caused by the company’s vaginal-mesh implant, Avaulta Plus , resulted in a $5.5 million verdict to be paid 60% by Bard, and 40% by the physician who implanted the device in 2008. The physician was not named as a defendant in the case, and court filings indicate that he will not be held responsible for making up the remainder of the damages.
Hundreds of cases have been filed against Bard, Boston Scientific, and other makers of vaginal-mesh implants that have been used to treat pelvic organ prolapse or urinary incontinence.
for pelvic organ prolapse or urinary incontinence
(from
An Australian study researched
Lead researcher Susan Davis, PhD, andchair of women's health in the Monash University department of medicine at the Alfred Hospital in Melbourne, Australia said that the team hypothesized that some women were simply more disposed to the condition than others, and although the research points to this being the case, the cause is unclear. "Anatomy. Genetics. Who knows?" she said.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.